Zobrazeno 1 - 10
of 160
pro vyhledávání: ''
Autor:
Ana Beatriz Pascoal Lopes, Katia B Pagnano, Erich Vinicius De Paula, Flávia Luísa Dias-Audibert, Arthur Noin de Oliveira, Rodrigo Ramos Catharino, Jeany Delafiori, Valquíria Mariane Oliveira Póvoa
Publikováno v:
Medical oncology (Northwood, London, England). 38(9)
The Estudo de Descontinuacao de Imatinibe apos Pioglitazona (EDI-PIO) is a single-center, longitudinal, prospective, phase 2, non-randomized, open, clinical trial (NCT02852486, August 2, 2016 retrospectively registered) for the discontinuation of ima
Autor:
Adrian Krygier, Krzysztof Jamroziak, Marta Żebrowska-Nawrocka, Aleksandra Sałagacka-Kubiak, Ewa Balcerczak, Dagmara Szmajda-Krygier
Publikováno v:
Medical Oncology (Northwood, London, England)
CEBPA and c-MYC genes belong to TF and play an essential role in hematologic malignancies development. Furthermore, these genes also co-regulate with RUNX1 and lead to bone marrow differentiation and may contribute to the leukemic transformation. Und
Autor:
S. V. Saju, Anand Raja, Manikandan Dhanushkodi, Ganesarajah Selvaluxmy, Venkatraman Radhakrishnan, Trivadi S. Ganesan, Tenali Gnana Sagar
Publikováno v:
Medical oncology (Northwood, London, England). 36(3)
Germ cell tumors (GCTs) are one of the most common tumors in adolescents and young adults. There is paucity of data on GCT from low–middle-income countries (LMIC). The present study was conducted to assess the demographic features, clinical manifes
Autor:
Diego Serraino, Valentina Lupato, Fabio Matrone, Emanuela Vaccher, E. Palazzari, Jerry Polesel, F. Navarria, Vittorio Giacomarra, Giuseppe Fanetti, Paolo Collarile, Carlo Furlan, Giovanni Franchin, Carlo Gobitti, Silvia Birri, Emilio Minatel
Publikováno v:
Medical oncology (Northwood, London, England). 36(4)
Improvements in prognosis of head-and-neck squamous cell carcinoma (HNSCC) have paralleled with an increase in health-care costs, so that an economic evaluation is of growing importance. Presently, most of the evidence is from insurance-based studies
Autor:
Krzysztof Woźniczka, Grzegorz Helbig, Ewa Rzenno, Agata Wieczorkiewicz-Kabut, Iwona Grygoruk-Wiśniowska, Helena Krzemień, Anna Kopińska, Miroslaw Markiewicz, Małgorzata Kopera, Michał Wójciak, Anna Koclęga, Krzysztof Bialas
Publikováno v:
Medical Oncology (Northwood, London, England)
Splenectomy before allogeneic stem cell transplantation (ASCT) for patients with myelofibrosis (MF) remains a matter of debate, and conflicting results have been reported to date. The procedure seems to fasten post-transplant hematological recovery,
Autor:
Michihide Tokuhira, Keiji Sugimoto, Tomoiku Takaku, Noriyoshi Iriyama, Isao Fujioka, Hiroyuki Fujita, Maho Ishikawa, Tatsuya Kawaguchi, Yuta Kimura, Tomonori Nakazato, Norio Asou, Norio Komatsu, Eriko Sato, Yoshihiro Hatta, Masahiro Kizaki
Publikováno v:
Medical oncology (Northwood, London, England). 35(11)
Background and Aim: Treatment with a tyrosine kinase inhibitor (TKI) is the standard of care for patients with chronic myeloid leukemia (CML). Based on the results of the ENESTnd and DASISION studies, the European LeukemiaNet 2013 guidelines now reco
Autor:
Saori Takahashi, Maiko Abumiya, Tomoko Yoshioka, Masatomo Miura, Yoshihiro Kameoka, Akiko Mita, Naoto Takahashi
Publikováno v:
Medical oncology (Northwood, London, England). 35(6)
We investigated the effects of polymorphisms in NR1I2 (7635A>G, 8055C>T), CYP3A4 (20230G>A), ABCB1 (1199G>A, 1236C>T, 2677G>T/A, 3435C>T), and ABCG2 (421C>A) on the mean plasma trough concentrations (C0) of bosutinib at the steady-state in 30 Japanes
Autor:
Therese A. Dolecek, Quan Chen, John L. Villano, Thomas Pittman, Bin Huang, Catherine R. Garcia
Publikováno v:
Medical oncology (Northwood, London, England). 35(5)
Radiation increases survival in glioblastoma (GBM); however, 30% do not receive this treatment. We sought to identify characteristics associated with not receiving radiation and the impact on outcomes. We analyzed the Surveillance, Epidemiology, and
Autor:
Masami Watanabe, Yasuyuki Kobayashi, Yuki Maruyama, Yasutomo Nasu, Yosuke Mitsui, Takuya Sadahira, Motoo Araki, Koichiro Wada, Toyohiko Watanabe, Ryuta Tanimoto
Publikováno v:
Medical oncology (Northwood, London, England). 35(6)
Bleomycin pulmonary toxicity (BPT) has been well described in patients with germ cell tumors treated with bleomycin etoposide and cisplatin chemotherapy (BEP). To assess the prognostic impact of BPT, we retrospectively identified 52 patients who unde
Autor:
Carmen Loquai, Berenice M. Lang, Weyer-Elberich, D Faidt, A Peveling-Oberhag, A M Hötker, Stephan Grabbe
Publikováno v:
Medical oncology (Northwood, London, England). 35(3)
Despite new therapeutic options, metastatic melanoma remains to be one of the most fatal tumors. With the development of BRAF inhibitors and immune checkpoint inhibitors, overall survival could be prolonged significantly for the first time. Clinical